310 related articles for article (PubMed ID: 7531374)
1. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience with propafenone for cardiac arrhythmias in the young.
Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
[TBL] [Abstract][Full Text] [Related]
4. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.
Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M
J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851
[TBL] [Abstract][Full Text] [Related]
5. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
[TBL] [Abstract][Full Text] [Related]
6. [Tachycardias: considerations in childhood in the 90s].
Gutiérrez-Larraya F; Jabón A
An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
[No Abstract] [Full Text] [Related]
7. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study.
Chrysostomou C; Beerman L; Shiderly D; Berry D; Morell VO; Munoz R
Anesth Analg; 2008 Nov; 107(5):1514-22. PubMed ID: 18931208
[TBL] [Abstract][Full Text] [Related]
8. Atrial tachycardias in young adults and adolescents with congenital heart disease: conversion using single dose oral sotalol.
Rao SO; Boramanand NK; Burton DA; Perry JC
Int J Cardiol; 2009 Aug; 136(3):253-7. PubMed ID: 18653253
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.
Saul JP; Ross B; Schaffer MS; Beerman L; Melikian AP; Shi J; Williams J; Barbey JT; Jin J; Hinderling PH;
Clin Pharmacol Ther; 2001 Mar; 69(3):145-57. PubMed ID: 11240979
[TBL] [Abstract][Full Text] [Related]
10. Sotalol: a new class III antiarrhythmic agent.
Zanetti LA
Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
[TBL] [Abstract][Full Text] [Related]
11. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
Klingenheben T; Hohnloser SH
Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
[TBL] [Abstract][Full Text] [Related]
12. Is hospital admission for initiation of antiarrhythmic therapy with sotalol for atrial arrhythmias required? Yield of in-hospital monitoring and prediction of risk for significant arrhythmia complications.
Chung MK; Schweikert RA; Wilkoff BL; Niebauer MJ; Pinski SL; Trohman RG; Kidwell GA; Jaeger FJ; Morant VA; Miller DP; Tchou PJ
J Am Coll Cardiol; 1998 Jul; 32(1):169-76. PubMed ID: 9669266
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
Borggrefe M; Breithardt G
Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
[TBL] [Abstract][Full Text] [Related]
14. [Catheter ablation in supraventricular tachycardia].
Pitschner HF; Neuzner J
Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
[TBL] [Abstract][Full Text] [Related]
15. [Exogenous adenosine as an anti-arrhythmia agent].
Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
[TBL] [Abstract][Full Text] [Related]
16. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome.
Tanel RE; Walsh EP; Lulu JA; Saul JP
Am Heart J; 1995 Oct; 130(4):791-7. PubMed ID: 7572588
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of intravenous sotalol in the treatment of supraventricular tachycardia].
Denis J; Brunel P; Moisan A
Ann Cardiol Angeiol (Paris); 1988; 37(7):387-91. PubMed ID: 3064696
[TBL] [Abstract][Full Text] [Related]
18. [Experience with dl-sotalol in the treatment of supraventricular arrhythmia].
Trabulo M; Almeida M; Caires G; Mesquita A; Parreira L; Morgado F; Adragão P; Bonhorst D; Seabra-Gomes R
Rev Port Cardiol; 1996 Oct; 15(10):725-9, 696. PubMed ID: 9115766
[TBL] [Abstract][Full Text] [Related]
19. Early experience with intravenous sotalol in children with and without congenital heart disease.
Valdés SO; Miyake CY; Niu MC; de la Uz CM; Asaki SY; Landstrom AP; Schneider AE; Rusin CG; Patel R; Lam WW; Kim JJ
Heart Rhythm; 2018 Dec; 15(12):1862-1869. PubMed ID: 30003959
[TBL] [Abstract][Full Text] [Related]
20. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy].
Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A
Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
